#9 - Colgate-Palmolive (NYSE:CL)
Colgate-Palmolive (CL) RSI Score = 47.23
At first glance, it would seem that a stock like Colgate-Palmolive (NYSE:CL) would benefit from consumers stocking up on the company’s products. But initially, the company’s supply chain was being affected. However, that did not seem to affect the company’s fortune very much. In its most recent earnings report the company posted slight beats on the top and bottom lines. CL stock is basically flat for the year,
Analysts are optimistic about the future direction of the stock based on its relatively strong performance compared to its decline during the Great Recession. The stock was drawing bullish sentiment from hedge funds. To be fair, this may be a short-term play. This is particularly true as the nation begins to open up. However, even as more Americans begin to experiment with a new normal, there will be many that choose for a variety of reasons to stay indoors. And that would bode well for CL stock.
And value investors can take comfort in the fact that Colgate-Palmolive is a dividend king. This means it has increased its dividend every year for at least 50 years. This is particularly appealing as the Federal Reserve has announced that interest rates to near zero will be the case for the foreseeable future.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More - Current Price
- $95.43
- Consensus Rating
- Moderate Buy
- Ratings Breakdown
- 12 Buy Ratings, 9 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $105.11 (10.1% Upside)
